ACTU

Analyst Sentiment

Wall St. Consensus
Buy
1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$21.00
+701.5%
Consensus
$21.00
+701.5%
Bull
$21.00
+701.5%
12-Month Target Range1 analyst
$21.00$21.00$21.00
Current $2.62Consensus
Current Price
$2.62
Upside to Consensus
$18.38

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev
EPS
FY2028
Rev+435.46%
EPS
FY2029
Rev+104.41%
EPS

Earnings Surprises

Recent Analyst Actions

Apr 22, 2025Craig-Hallum
Craig-Hallum bullish on Actuate Therapeutics, initiates with a Buy
Target:$21.00
+146.5%from $8.52